Bruce Savage

Direct Capital Private Equity Ltd. (Direct Capital) is a private equity and venture capital investment firm headquartered in Auckland, New Zealand founded by Ross George and Mark Hutton in 1994.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Cleveland Biosensors Pty Ltd. develops and distributes biosensor instruments. It offers Biofiniti, a portable point-of-care diagnostic system that enables the early diagnosis of disease and health disorders in a range of clinical settings, as well as performs tests on a small disposable cartridge that contains various necessary reagents. The firm's hand-held instrument BioFiniti, allows users to conduct rapid, analysis on a wide variety of samples. The company was founded in 2001 and is headquartered in Brisbane, Australia.

EnCoate Holdings Ltd. develops food-grade biopolymer technologies. The company was founded in 2003 and is headquartered in Lincoln, New Zealand.

Wool Equities Ltd. develops, manufactures and distributes wool products. It has retail and distribution access in the U.S. The company was founded on August 29, 1997 and is headquartered in Palmerston North, New Zealand.

Biopacific Partners, Inc. acts as an alternative investment manager. The private company is based in Auckland, New Zealand. The New Zealander company was founded by Andrew Philip Kelly.

Focus Genetics SA Ltd. engages in livestock genetics research and development. It enhances genetics in sheep, cattle and deer and markets these genetics to farmers throughout New Zealand. The company was founded on June 29, 2007 and is headquartered in Napier, New Zealand.

AgResearch Ltd. engages in research and development activities in the pastoral sector. It offers NaturOTM analgesia system, CARLA Saliva Test, WormFEC and MicroManual products. Its services include bioinformatics, development engineering, farms and deoxyribonucleic acid testing laboratory. The company was founded in 1992 and is headquartered in Hamilton, New Zealand.

Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland.

BioPacific Ventures Ltd, a joint venture between Inventages Venture Capital, New Zealand based Direct Capital, and NZ government research organization AgResearch, invests in life science companies located in New Zealand and Australia with strong management teams. It targets companies operating in the fields of agriculture, health & wellness, functional & medical foods, nutraceuticals, cosmeceuticals, skin care, dietary supplements, infant & sports nutrition, immune stimulation and anti-aging therapies. It acts as a lead investor and provides financing for startup, seed and early stage capital requirements with an investment size ranging from NZ$2 - NZ$10 million. It takes a seat on the board of directors and also considers co-investments.